Τελευταία νέα :

European Hematology Association - Frequently asked questions regarding SARS-CoV2 in cancer patients

Κατηγορία Νέα / Ειδήσεις
Διαβάστηκε 4680 φορές

Recommendations for hematologists in COVID-19 crisis COVID-19, caused by SARS-CoV-2, is expected to be a devastating infection in patients with active cancer. It should be taken seriously and managed rigorously without jeopardizing the curative chance of individual cancer patients. In view of the rapidly changing evidence and general situation the EHA Scientific Working Group Infections in Hematology has developed key questions and answers on the management of cancer patients with or at risk of COVID-19 

EHA-SWB-Infect-Manuscript-FAQ-COVID19

Τελευταία τροποποίηση στις Παρασκευή, 10 Απριλίου 2020 11:22

Δημοφιλέστερα

Συνέδρια άλλων εταιρειών

Συνέδρια άλλων εταιρειών

28 Ιουλ 2016 Συνέδρια άλλων εταιρειών